NDC 68982-141

NUWIQ

Antihemophilic Factor (recombinant)

NUWIQ is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is .

Product ID68982-141_052ca8a8-a25d-2ea0-9080-b49091286057
NDC68982-141
Product TypePlasma Derivative
Proprietary NameNUWIQ
Generic NameAntihemophilic Factor (recombinant)
Dosage FormKit
Route of AdministrationINTRAVENOUS
Marketing Start Date2016-01-01
Marketing CategoryBLA / BLA
Application NumberBLA125555
Labeler NameOctapharma USA Inc
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68982-141-01

1 KIT in 1 CARTON (68982-141-01) * 2.5 mL in 1 VIAL (68982-142-01) * 2.5 mL in 1 VIAL (68982-901-01)
Marketing Start Date2016-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68982-141-01 [68982014101]

NUWIQ KIT
Marketing CategoryBLA
Application NumberBLA125555
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2016-01-01

Drug Details

NDC Crossover Matching brand name "NUWIQ" or generic name "Antihemophilic Factor (recombinant)"

NDCBrand NameGeneric Name
68982-139NUWIQNUWIQ
68982-143NUWIQNUWIQ
68982-147NUWIQNUWIQ
68982-149NUWIQNUWIQ
68982-141NUWIQNUWIQ
68982-145NUWIQNUWIQ
68982-151NUWIQNUWIQ
0026-3782Kogenate FSAntihemophilic Factor (Recombinant)
0026-3783Kogenate FSAntihemophilic Factor (Recombinant)
0026-3785Kogenate FSAntihemophilic Factor (Recombinant)
0026-3786Kogenate FSAntihemophilic Factor (Recombinant)
0026-3787Kogenate FSAntihemophilic Factor (Recombinant)
0026-3821KovaltryAntihemophilic Factor (Recombinant)
0026-3822KovaltryAntihemophilic Factor (Recombinant)
0026-3824KovaltryAntihemophilic Factor (Recombinant)

Trademark Results [NUWIQ]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NUWIQ
NUWIQ
79138098 4496748 Live/Registered
Octapharma AG
2013-08-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.